Jan 13 | News
NEW YORK (AP) — Teva has confirmed it plans to market a new form of the powerful and addictive painkiller hydrocodone, worrying experts who fear a narcotics "arms race" that could worsen a national problem with prescription drug abuse.
|
Jan 4 | News
In 2009, Teva Animal Health Incorporated, the largest U.S. manufacturer of generic animal drugs, was ordered by the FDA to cease operations at its facility in St. Joseph, Missouri.
|
Dec 8 2011 | Video
CNN reports on Katherine Sebelius' decision that the "morning-after pill" will not be available to all ages without a prescription.
|
Dec 8 2011 | News
WASHINGTON (AP) — It's the morning after and the controversy over how to sell emergency contraception still looms.
The Obama administration's top health official stopped plans Wednesday to let the Plan B morning-after pill move onto drugstore shelves next to the condoms.
|
Dec 7 2011 | News
Teva Pharmaceuticals wants its Plan B morning-after pill to become the first truly over-the-counter form of emergency contraception.
|
Dec 2 2011 | News
In a complaint filed in a U.S. court, Pfizer and Teva have been accused by five prescription drug retailers of violating antitrust law by conspiring to delay the launch of a generic version of Effexor XR (venlafaxine).
|
Dec 1 2011 | News
Teva announced Thursday that U.S. regulators granted tentative approval to its generic version of Pfizer’s Lipitor (atorvastatin).
|
Nov 22 2011 | News
JERUSALEM (AP) — Eli Hurvitz, the onetime laboratory dishwasher who transformed Teva Pharmaceutical Industries from a small Israeli medical company into the world's largest generic drugmaker, has died. He was 79.
|
Nov 3 2011 | News
The Procter & Gamble Company and Teva Pharmaceutical Industries Ltd. today announced the creation of a new partnership and joint venture (JV) in consumer health care. The JV, to be named PGT Healthcare, will be headquartered in Geneva, Switzerland and will operate in essentially all markets outside of North America.
|
Nov 2 2011 | News
Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, said Wednesday its third-quarter profit fell 13 percent as North American sales dropped, partly because of a lack of significant new generic drug launches.
|